Fintrics Logo

Educational US stock analysis from public filings and macro data, built to make company research clearer, faster, and easier to compare.

support@fintrics.ioFintrics PTY LTD
XLinkedIn

Product

  • Stock research platform
  • Stock analysis platform
  • Stock comparison tool
  • Portfolio analysis tool
  • Stock scoring system

Research

  • Stocks
  • Reports
  • Methodology
  • Data policy

Company

  • About
  • Pricing
  • Blog
  • Help center
  • Contact support

Legal

  • Privacy policy
  • Terms of service
  • Cookie policy
  • Legal hub
  • Delete account

© 2026 Fintrics PTY LTD. All rights reserved.

PrivacyTermsCookiesLegal
Fintrics
DashboardStocksWatchlistSectorsPortfolios
A.A.
DashboardStocksWatchlistSectorsPortfoliosAccount
WorkspaceDashboardStocksWatchlistSectorsPortfolios

Latest trends

Fintrics ShellLive
Navigation MobilePinned
Workspace RouteShared
Research ContextReady

Fintrics Shared app chrome keeps the header and bottom navigation mounted while the content pane swaps route content.

DashboardStocksWatchlistSectorsPortfoliosAdvanced
Stocks/ABCL

AbCellera Biologics Inc. logo
ABCL

AbCellera Biologics Inc.

Sector unavailable. Latest Fintrics report: Jul 2026. 13 usable metrics / 37 monthly reports.

AbCellera Biologics Inc. is a publicly traded company available in the Fintrics stock universe. Fintrics includes this overview as always-visible business context so usersRead more...AbCellera Biologics Inc. is a publicly traded company available in the Fintrics stock universe. Fintrics includes this overview as always-visible business context so users can understand the company before reviewing scores, filings, and other report data.Read less...
OverviewFintrics scoresScore historyCompany metricsFilings dataInsider trading
ABCL research snapshotABCL filing and sector snapshot
Revenue$8.3M

Mar '26

Gross profit-

No current EDGAR row

Free cash flow$-37.4M

Mar '26

Latest filing4

Jul 6, 2026

Next filingPending

No scheduled SEC filing date loaded

Insider activityM $47,500

Booth Andrew / Jun 2

Five Fintrics score familiesFintricsOverallSectorScoreCompanyHealthCompanyProfitabilityFintricsCompany
Report score mix
  • Fintrics Overall ScoreOverall stock score across company and sector context.
  • Sector ScoreSector macro score used in the broader context layer.
  • Fintrics Company HealthLiquidity, leverage, and return-quality inputs.
  • Fintrics Company ProfitabilityRevenue, margins, EPS, and cash-flow inputs.
  • Fintrics Company ScoreCompany-only score from profitability and health.
ABCL revenue and income
Dec '22Revenue$21.5MNet income$-29.9MDec '22Mar '23Revenue$12.2MNet income$-40.1MJun '23Revenue$10.1MNet income$-30.5MJun '23Sep '23Revenue$6.6MNet income$-28.6MDec '23Revenue$9.2MNet income$-47.2MDec '23Mar '24Revenue$10MNet income$-40.6MJun '24Revenue$7.3MNet income$-36.9MJun '24Sep '24Revenue$6.5MNet income$-51.1MDec '24Revenue$5.1MNet income$-34.2MDec '24Mar '25Revenue$4.2MNet income$-45.6MJun '25Revenue$17.1MNet income$-34.7MJun '25Sep '25Revenue$9MNet income$-57.1MDec '25Revenue$44.9MNet income$-8.9MDec '25Mar '26Revenue$8.3MNet income$-43.2MMar '26
$8.3M▲$-43.2M
Revenue$8.3MMar 2026▼
Net income$-43.2MMar 2026▼
Apple Fintrics score peer comparisonCompany + macro
ABCL AbCellera Biologics Inc. / Overall 4.3 / Company 4.6 / Profitability 4.6 / Health 4.6 / Macro 3.8 / Jul 2026Overallscore
AbCellera Biologics Inc.

ABCL Fintrics scores

4.3
Fintrics

Macro & company

4.6
Company

Company score

3.8
Macro

Macro score

ABCL score history
ABCL SEC filing data
ABCL market news
ABCL sector rail
ABCL insider activity